<DOC>
	<DOCNO>NCT00301041</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Giving radiation therapy different way may kill tumor cell . PURPOSE : This randomized clinical trial study side effect best way give radiation therapy see well work treat patient invasive breast cancer .</brief_summary>
	<brief_title>Radiation Therapy Treating Women With Invasive Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare ratio post- pre-treatment plasma transform growth factor-beta 1 ( TGF-β ) woman invasive breast cancer undergo hypofractionated radiotherapy vs standard-fractionated external-beam radiotherapy . Secondary - Establish longitudinal serum plasma biorepository retrospective evaluation TGF-β biomarkers special relevance radiation response . - Correlate pre-treatment plasma TGF-β level clinical fibrosis development . OUTLINE : This randomize study . Patients randomize 1 2 treatment arm . - Arm I ( hypofractionated radiotherapy ) : Patients undergo external-beam radiotherapy daily 5 day week 3.5 week ( 16 fraction total ) . - Arm II ( standard fractionate radiotherapy ) : Patients undergo radiotherapy arm I low dose 5 week ( 25 fraction total ) . After completion study treatment , patient follow every 6 month 2 year annually 3 year . PROJECTED ACCRUAL : A total 100 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm invasive breast cancer Underwent lumpectomy ( breastpreserving surgery ) without adjuvant chemotherapy within past 12 week Histologically negative surgical margin ( i.e. , tumor ink ) Candidates postoperative breast radiotherapy Determined need radiotherapy regional node ( e.g. , third supraclavicular field ) Hormone receptor status specify PATIENT CHARACTERISTICS : Female Menopausal status specify Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No history scleroderma systemic lupus erythematosis No prior concurrent malignancy except nonmelanoma skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior breast radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>invasive ductal breast carcinoma</keyword>
	<keyword>invasive lobular breast carcinoma</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
</DOC>